Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TiterMax USA
Norcross, Georgia, United Statestitermax.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TiterMax USA manufactures immunological adjuvants for research use, primarily formulated to induce cell-mediated and humoral immune responses in laboratory animals. Their flagship product, TiterMax Classic, is a potent, non-toxic alternative to Freund’s Complete Adjuvant and is not itself a therapeutic or clinical-stage asset but an ancillary reagent for biomedical research[1][2][3][6][7][9].
- Modalities
- Adjuvant (immunological adjuvant)Water-in-oil emulsion
- Industry
- Non-Drug Biotech
02
Partnerships
Sigma-Aldrich (distributor)[7][9]HiSS Diagnostics (distributor)[2]Funakoshi (Japan distributor)[8]CedarLane Laboratories (Canada distributor)[8]Stratech Scientific (UK distributor)[8]Advanced Biotechnology Laboratories (Taiwan distributor)[8]
Beyond the preview
Go deeper on TiterMax USA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TiterMax USA.